vs
MARKETWISE, INC.（MKTW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
MARKETWISE, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$83.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -14.4%），MARKETWISE, INC.自由现金流更多（$45.6M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -12.5%）
MarketWise Inc.是一家领先的投资研究、金融市场数据及财富管理教育解决方案提供商，服务覆盖北美、欧洲及亚太地区的个人与机构投资者，核心产品包括实用市场洞察、投资组合分析工具及多资产类别专项研究内容。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MKTW vs PBYI — 直观对比
营收规模更大
MKTW
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出42.2%
-14.4%
自由现金流更多
MKTW
多$31.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
-12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.4M | $75.5M |
| 净利润 | $1.9M | — |
| 毛利率 | 87.0% | 69.3% |
| 营业利润率 | 15.8% | 22.7% |
| 净利率 | 2.3% | — |
| 营收同比 | -14.4% | 27.7% |
| 净利润同比 | -9.8% | — |
| 每股收益（稀释后） | $0.79 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MKTWPBYI
| Q4 25 | $83.4M | $75.5M | ||
| Q3 25 | $81.3M | $54.5M | ||
| Q2 25 | $80.0M | $52.4M | ||
| Q1 25 | $83.5M | $46.0M | ||
| Q4 24 | $97.5M | $59.1M | ||
| Q3 24 | $97.2M | $80.5M | ||
| Q2 24 | $105.0M | $47.1M | ||
| Q1 24 | $109.0M | $43.8M |
净利润MKTWPBYI
| Q4 25 | $1.9M | — | ||
| Q3 25 | $1.5M | $8.8M | ||
| Q2 25 | $1.3M | $5.9M | ||
| Q1 25 | $890.0K | $3.0M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $1.7M | $20.3M | ||
| Q2 24 | $1.5M | $-4.5M | ||
| Q1 24 | $1.7M | $-4.8M |
毛利率MKTWPBYI
| Q4 25 | 87.0% | 69.3% | ||
| Q3 25 | 87.0% | 77.7% | ||
| Q2 25 | 86.3% | 76.5% | ||
| Q1 25 | 85.7% | 77.1% | ||
| Q4 24 | 88.7% | 76.4% | ||
| Q3 24 | 86.7% | 63.9% | ||
| Q2 24 | 87.3% | 77.4% | ||
| Q1 24 | 87.7% | 75.5% |
营业利润率MKTWPBYI
| Q4 25 | 15.8% | 22.7% | ||
| Q3 25 | 21.9% | 17.6% | ||
| Q2 25 | 18.5% | 12.7% | ||
| Q1 25 | 20.1% | 8.7% | ||
| Q4 24 | 24.8% | 22.6% | ||
| Q3 24 | 22.5% | 27.4% | ||
| Q2 24 | 20.3% | -4.6% | ||
| Q1 24 | 19.8% | -5.3% |
净利率MKTWPBYI
| Q4 25 | 2.3% | — | ||
| Q3 25 | 1.9% | 16.2% | ||
| Q2 25 | 1.6% | 11.2% | ||
| Q1 25 | 1.1% | 6.5% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 1.8% | 25.2% | ||
| Q2 24 | 1.5% | -9.6% | ||
| Q1 24 | 1.5% | -11.0% |
每股收益（稀释后）MKTWPBYI
| Q4 25 | $0.79 | $0.26 | ||
| Q3 25 | $0.58 | $0.17 | ||
| Q2 25 | $0.53 | $0.12 | ||
| Q1 25 | $0.41 | $0.06 | ||
| Q4 24 | $1.06 | $0.40 | ||
| Q3 24 | $0.87 | $0.41 | ||
| Q2 24 | $0.80 | $-0.09 | ||
| Q1 24 | $0.85 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $70.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-11.7M | $130.3M |
| 总资产 | $218.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MKTWPBYI
| Q4 25 | $70.1M | $97.5M | ||
| Q3 25 | $50.5M | $94.4M | ||
| Q2 25 | $69.1M | $96.0M | ||
| Q1 25 | $79.2M | $93.2M | ||
| Q4 24 | $97.9M | $101.0M | ||
| Q3 24 | $94.1M | $96.7M | ||
| Q2 24 | $109.3M | $96.8M | ||
| Q1 24 | $131.2M | $107.2M |
总债务MKTWPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $707.0K | $102.0M |
股东权益MKTWPBYI
| Q4 25 | $-11.7M | $130.3M | ||
| Q3 25 | $-14.5M | $115.3M | ||
| Q2 25 | $-15.8M | $104.7M | ||
| Q1 25 | $-15.8M | $97.1M | ||
| Q4 24 | $-12.5M | $92.1M | ||
| Q3 24 | $-19.5M | $71.1M | ||
| Q2 24 | $-23.7M | $48.5M | ||
| Q1 24 | $-9.4M | $51.0M |
总资产MKTWPBYI
| Q4 25 | $218.4M | $216.3M | ||
| Q3 25 | $201.7M | $202.9M | ||
| Q2 25 | $211.8M | $194.9M | ||
| Q1 25 | $239.6M | $196.2M | ||
| Q4 24 | $259.5M | $213.3M | ||
| Q3 24 | $278.4M | $220.7M | ||
| Q2 24 | $315.3M | $205.0M | ||
| Q1 24 | $359.3M | $214.1M |
负债/权益比MKTWPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $45.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 54.6% | 19.1% |
| 资本支出强度资本支出/营收 | 0.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 23.84× | — |
| 过去12个月自由现金流最近4个季度 | $67.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MKTWPBYI
| Q4 25 | $46.0M | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $17.8M | $14.1M | ||
| Q1 25 | $1.7M | $3.6M | ||
| Q4 24 | $-22.1M | $15.6M | ||
| Q3 24 | $-5.8M | $11.0M | ||
| Q2 24 | $-3.8M | $1.0M | ||
| Q1 24 | $-18.5M | $11.2M |
自由现金流MKTWPBYI
| Q4 25 | $45.6M | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $17.7M | $14.1M | ||
| Q1 25 | $1.7M | $3.6M | ||
| Q4 24 | $-22.3M | $15.6M | ||
| Q3 24 | $-5.9M | $11.0M | ||
| Q2 24 | $-3.8M | $1.0M | ||
| Q1 24 | — | — |
自由现金流率MKTWPBYI
| Q4 25 | 54.6% | 19.1% | ||
| Q3 25 | 2.7% | 17.7% | ||
| Q2 25 | 22.2% | 26.8% | ||
| Q1 25 | 2.0% | 7.7% | ||
| Q4 24 | -22.9% | 26.4% | ||
| Q3 24 | -6.0% | 13.7% | ||
| Q2 24 | -3.6% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度MKTWPBYI
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率MKTWPBYI
| Q4 25 | 23.84× | — | ||
| Q3 25 | 1.44× | 1.10× | ||
| Q2 25 | 13.76× | 2.41× | ||
| Q1 25 | 1.95× | 1.21× | ||
| Q4 24 | -10.36× | — | ||
| Q3 24 | -3.39× | 0.54× | ||
| Q2 24 | -2.46× | — | ||
| Q1 24 | -11.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
